Today: 28 June 2026
Browse Category

NYSE:ABT 7 July 2025 - 20 November 2025

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott to Acquire Exact Sciences for $21 Billion in Cancer Screening Mega-Deal

Abbott will acquire Exact Sciences for $105 per share in cash, valuing the deal at about $23 billion including debt. The boards of both companies approved the transaction, which is set to close in the second quarter of 2026 pending shareholder and regulatory approval. Exact Sciences will become a subsidiary, expanding Abbott’s diagnostics revenue and portfolio. The offer represents a 21–22% premium to Exact’s last closing price.
20 November 2025
··
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire Exact Sciences, sources told Bloomberg on Wednesday, in what would be Abbott’s largest deal since 2016. Exact Sciences shares surged up to 29% intraday, reaching a market value near $16 billion, while Abbott stock fell around 3%. No official comments have been made by either company.
19 November 2025
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 20.10.2025

Fed Chair Jerome Powell signaled the central bank may soon pause its balance-sheet runoff, hinting at an end to quantitative tightening. The move could ease monetary conditions and support stocks, though risks remain if earnings weaken. AbbVie and Abbott Laboratories continue to deliver steady dividend growth, appealing to long-term income investors. Walmart’s new OpenAI partnership and AI-driven features have lifted its shares despite sector headwinds.
20 October 2025
···
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

ABT shares closed at $128 on Oct. 15, down 3.5% for the day and about 2% for the week. Abbott reported Q3 revenue of $11.37 billion, up 6.9% year-over-year but slightly below estimates; adjusted EPS matched forecasts at $1.30. Medical Devices drove growth, while Diagnostics fell 6.6%. Investors sold off the stock after in-line results, with analysts maintaining a Hold rating and a $143.50 median price target.
15 October 2025
··
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

Biobeat’s cuffless vital-sign patch received FDA clearance and CE marking for remote hospital monitoring. PharmaSens and SiBionics unveiled the niia™ signature patch, combining a continuous glucose monitor and insulin pump, at ADA 2025. Fasikl’s Felix NeuroAI Wristband became the first FDA-cleared neuromodulation wearable for essential tremor. U.S. HHS Secretary RFK Jr. launched the MAHA initiative for nationwide wearable adoption.
7 July 2025
···
1 2 3

Stock Market Today

  • Ford Shares Rise as Quality Improves Despite Recall Concerns
    June 28, 2026, 4:47 PM EDT. Ford Motor Company shares edged up to $14.13, up 0.14% on Friday, starting a shortened four-day trading week ahead of U.S. Independence Day. The automaker's stock gained 0.5% for the week, outperforming General Motors and Stellantis. Ford led mass-market brands in J.D. Power's 2026 Initial Quality Study with 152 problems per 100 vehicles, versus the industry average of 175, marking significant improvement. However, recall risks persist, with Ford recording 51 recalls in 2026, the highest in the industry, and remaining under federal scrutiny for delayed rearview camera recall actions. CEO Jim Farley and COO Kumar Galhotra emphasized a focus on quality and reduced warranty costs, projecting continued improvement through 2026.

Latest articles

Nu Holdings shares finish up for the week after Needham call

Nu Holdings shares finish up for the week after Needham call

28 June 2026
Nu Holdings (NYSE:NU) surged 5.7% to $13.17 Friday, flipping its week to a 3.6% gain and outperforming both the iShares MSCI Brazil ETF and the Nasdaq, after Needham initiated coverage with a $17 price target, citing a “scaled and profitable customer base” and expected U.S. expansion within a year.
MARA stock: Long Ridge power deal in focus as bitcoin slides in holiday week

MARA stock: Long Ridge power deal in focus as bitcoin slides in holiday week

28 June 2026
MARA closed Friday up 4.5% at $14.54 as investors weigh its $2.10 billion bitcoin holding—now 38% of equity value, down $311 million since March—against new power-asset exposure from the $1.5 billion Long Ridge deal, with Q2’s end and bitcoin’s price set to drive the stock in a short trading week.
Go toTop